SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Adtegrity (Pink Sheets: ADTY), a Grand Rapids, Mich.-based company specializing in Internet advertising networks and services, today reported its results for the third quarter ended Sept. 30, 2014.

The Company’s unaudited results included net income of $80,892 for the third quarter on revenues of $4.3 million, compared with a net income of $419,215 on revenues of $5.03 million for the same quarter last year.

“Unfortunately, our recent investments in headcount didn’t translate to improvements in our financial performance.  We have also experienced slower-than-expected market growth in political ad spending for the year.  At the same time, we believe we have a solid plan, we remain profitable and we are optimistic that we will see increased sales momentum as we move forward,” said Adtegrity President and CEO Scott Brew. “We remain focused on taking Adtegrity to the next level of performance, and will continue to invest in growing the company.”

Adtegrity reported serving more than 47.6 billion ad impressions during the third quarter, resulting in 27.9 million clicks and 395,000 conversions for Adtegrity advertisers.

Adtegrity’s primary business is the delivery of interactive advertising and marketing services. Since its founding in 1999, the Company has established itself as a results-driven, customer-focused firm providing consistent quality to the top advertising brands online.  Adtegrity currently delivers billions of advertisements across thousands of top-tier websites each month.